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Abstract
Caffeine increases sympathetic nerve activity in healthy individuals. Such modulation of
nervous system activity can be tracked by assessing the heart rate variability. This study
aimed to investigate the influence of caffeine on time- and frequency-domain heart rate var-
iability parameters, blood pressure and tidal volume in paraplegic and tetraplegic compared
to able-bodied participants. Heart rate variability was measured in supine and sitting posi-
tion pre and post ingestion of either placebo or 6 mg caffeine in 12 able-bodied, 9 paraplegic
and 7 tetraplegic participants in a placebo-controlled, randomized and double-blind study
design. Metronomic breathing was applied (0.25 Hz) and tidal volume was recorded during
heart rate variability assessment. Blood pressure, plasma caffeine and epinephrine con-
centrations were analyzed pre and post ingestion. Most parameters of heart rate variability
did not significantly change post caffeine ingestion compared to placebo. Tidal volume sig-
nificantly increased post caffeine ingestion in able-bodied (p = 0.021) and paraplegic (p =
0.036) but not in tetraplegic participants (p = 0.34). Systolic and diastolic blood pressure
increased significantly post caffeine in able-bodied (systolic: p = 0.003; diastolic: p = 0.021)
and tetraplegic (systolic: p = 0.043; diastolic: p = 0.042) but not in paraplegic participants
(systolic: p = 0.09; diastolic: p = 0.33). Plasma caffeine concentrations were significantly
increased post caffeine ingestion in all three groups of participants (p<0.05). Plasma epi-
nephrine concentrations increased significantly in able-bodied (p = 0.002) and paraplegic
(p = 0.032) but not in tetraplegic participants (p = 0.63). The influence of caffeine on the
autonomic nervous system seems to depend on the level of lesion and the extent of
the impairment. Therefore, tetraplegic participants may be less influenced by caffeine
ingestion.
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It is already well-known, that a spinal cord injury implies some crucial physiological adapta-
tions due to the injury. Such consequences include not only bone mass, active muscle mass or
the inability to use the limbs, but also gastrointestinal transition time, bladder, bowel and sex-
ual functions as well as cardiovascular capacity and the activation of the autonomous nervous
system [1–6]. As the sympathetic nerves leave the spine between Th1 and L2, loss of function
highly depends on the level and severity of the lesion.Whereas in paraplegic patients sympa-
thetic nerve activity is almost fully preserved, tetraplegic patients mostly suffer from the inabil-
ity to activate sympathetic nervous system [7].
Heart rate variability (HRV) is a non-invasive measure of markers of cardiac autonomic
modulation.With power spectral analysis, R-peak to R-peak intervals (RRI) of consecutive
heart beats can be divided into low frequency (LF) and the high frequency (HF) power. It is
generally accepted that HF is a marker of cardiac parasympathetic activity [8] and that LF fluc-
tuations of HRV at rest are not related to muscle sympathetic nerve activity [9]. However,
whenmeasured in an orthostatic challenge, it has been shown that LF/HF power ratio and
muscle sympathetic nerve activation change in parallel [10, 11], suggesting that this HRV ratio
may reflect enhanced adrenergic activity as response to provoked stress.
It was previously shown that HRV measurements are reproducible in able-bodied as well as
in spinal cord injured participants [12]. Bunten, Warner [13] found that HRV is altered follow-
ing a spinal cord injury mainly due to a loss of sympathetic nervous tone corresponding to a
loss of LF. Some other studies investigated HRV during exercise [14–16], in head-up tilt [17]
or during rest [18–21] in paraplegic and tetraplegic individuals. Inoue, Ogata [22] found no LF
in 9 out of 15 tetraplegic participants which confirms that LF implies not only a sympathetic
component but also parasympathetic part [8]. As caffeine acts as a stimulant, it appeared to be
a good tool to further investigate its influence on the autonomous nervous system in paraplegic
and tetraplegic individuals [23, 24]. Furthermore, caffeine was shown to have some ergogenic
effects on exercise performance in various sports disciplines [25–27]. Therefore, its effects on
the autonomic nervous system need to be investigated before an application in athletes with a
spinal cord injury as well. Investigating the effects of caffeine on the autonomic nervous system
in individuals with a spinal cord injury will therefore provide more information about the
mechanism of action of this stimulant. In addition, it might help to evaluate whether this stim-
ulant in such a high dose is still safe in these subjects. Therefore, our aim was to investigate,
whether caffeine alters HRV, blood pressure and plasma epinephrine and norepinephrine con-
centrations compared to placebo in paraplegic and tetraplegic patients compared to able-bod-
ied participants. Additionally, we aimed to assess the differences in baselineHRV between high
lesioned tetraplegic, low lesioned paraplegic and able-bodiedparticipants. As HRV was known
to be influenced by respiration [28] and caffeine induces bronchodilation [29], tidal volume
was recorded during metronomic breathing as it might confound HRV results.
Materials and Methods
Participants
A double-blind, placebo-controlled and randomized study design was chosen (S1 File). Partici-
pants were included if they were healthy, non-smokingmen between 18 and 60 years old. They
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had to be physically active for a minimum of three times 45 minutes per week. All participants
with a spinal cord injury were motor and sensory complete lesioned. Participants with a para-
plegia showed a lesion level below Th10 and participants with a tetraplegia a lesion level
betweenC5 and C7. Drugs affecting the cardiovascular functionwere not allowed whereas the
intake of any other drugs was kept constant throughout the trials. Participants suffering from
diabetes were excluded from study participation. No changes were made to the study protocol
after study commencement.
During the testing phase, participants followed their habitual training patterns and did not
increase or decrease training volume. Light training sessions were performed the last two days
prior the trial. Participants didn`t drink any alcohol 24 hours before the test session. They
abstained from caffeine on the test day. The diet during the study phase was self-selected and
ad libitum. Participants were asked to eat breakfast exactly 2 hours before the start of the mea-
surements and to replicate the meal on the second trial. A nutrition and exercise protocol was
filled out together with the participant before the start of the test session to check if the partici-
pants followed these instructions. Participants were asked to sleep at least seven hours the two
nights before the measurements. They were excluded from data analysis if they violated any of
these conditions. All tests were performed in our sports medicine laboratory where tempera-
ture (22°C) and humidity (40%) were kept constant. The two tests were performed at least 2
days and at most 2 weeks apart from each other at the same time of the day.
The study was approved by the local ethical committee (Ethikkommission Nordwest- und
Zentralschweiz, EKNZ, Basel, Switzerland) and written informed consent was obtained from
the participants prior starting the study. All procedures (S2 File) were in accordance with the
ethical standards of the institutional and national research committee and with the 1964 Hel-
sinki Declaration.
Experimental design
Each participant visited the laboratory on three different occasions.On the first visit written
informed consent was obtained. A questionnaire for medical history was used to check if the par-
ticipants fulfilled inclusion criteria and therefore, to mitigate the cardiopulmonary risk. They were
asked for their regular caffeine consumption (i.e. how often and howmany cups of coffee, black
tee, energy drinks per week?) and their sports activity. Caffeine intake was then quantified taking
into account the frequency, the amount and the product consumed by the participant per week
and then divided by seven to get the average daily caffeine consumption. A first measurement for
HRV was performed to become accustomed to the experimental protocol and to check fixing of
the spinal cord injured individuals. In addition, a ramp test to exhaustion at an arm crank ergome-
ter (Ergoline GmbH, Bitz, Germany) starting at 20Wwith an increment of 1W every 6 s was
used to determineVO2peak (Oxycon Pro, CareFusion Germany, Hoechberg,Germany).
On the second and third visit, participants were placed onto a couch in supine position in a
dark and quiet room and rested for 10min. Afterwards,HRV assessment started in supine fol-
lowed by sitting position. Subsequently, a blood sample was taken from the antecubital vein.
Thereafter, the participant had to ingest a gelatin capsule either containing placebo or caffeine.
A break of 40 min provided enough time for absorption [30]. The ingestion of any food or per-
forming physical activity were prohibited during this period.After the 40 min break, a second
HRV assessment was performedwith a 10 min resting period in supine position beforehand.
Subsequently, a second blood sample was collected to analyze plasma caffeine, epinephrine and
norepinephrine concentrations.
Main outcome parameters were HRV parameters before and after caffeine or placebo inges-
tion under resting conditions. Furthermore, we were interested in plasma epinephrine,
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norepinephrine and caffeine concentrations pre and post supplement ingestion. Secondary
outcome parameters were tidal volume during HRV measurements as well as systolic and dia-
stolic blood pressure.
Heart rate variability
AHRV assessment consisted out of 6 min measurement in supine position and another 6 min
in sitting position. Paced breathing (15 breaths per min, 0.25 Hz) was applied provided
through and audio recording for standardization purposes. The sitting position was achieved
passively by increasing the backrest up to 60°. All tetraplegic participants were able to stabilize
their upper body by themselves while sitting.
The RRI were recorded using a heart rate monitor (RS800CX, Polar ElectroOy, Kempele,
Finland) with a sample frequency of 1000 Hz. Data was transferred to a software (Polar Pro-
Trainer, Polar ElectroOy, Kempele, Finland) where the information was stored as a text-file
for further analysis with the Kubios software (Kubios, Department of Applied Physics, Univer-
sity of Eastern Finland, Kuopio, Finland). Any signals interfering with the analysis were
removed using an appropriate artifact correction factor [31].
Stationary segments of at least 2 min and at most 5 min were analyzed for supine and sitting
position. The length of all analyzed data segments were always the same within a participant.
The segment in supine position ended at the highest point in the RRI before the decrease of the
curve had started. The segment in sitting position started right after the one in supine position
ended.Markers of cardiac parasympathetic activity were analyzed from the segment recorded
in supine position whereas markers of sympathetic activity were analyzed from the segment
recorded in sitting position. The time domain parameters, MeanRR (mean value of all RRI
within a segment), SDNN (standard deviation of all normal RRI) and RMSSD (root of the
mean squared differences of successive RRI), and the Fast Fourier Transformation (FFT) were
used to analyze RR time series. For FFT 256 consecutive beats were analyzed. Oscillation with
frequencies from 0.04 to 0.15 Hz were classified as LF and frequencies of 0.15 to 0.40 Hz as HF.
The absolute power of each frequencywas expressed as ms2 and was calculated by integrating
the area under the curve. The ratio of LF to HF power (LF/HF) was calculated using the abso-
lute power of LF and HF. HF and LF in normalized units (HFn.u. and LFn.u.) were not
reported due to their redundancy with LF/HF power ratio [32].
Blood pressure and tidal volume
Blood pressure was recorded at the left arm in the 9th minute of each 10 min resting perioddur-
ing the first and the secondHRV measurement using an automated blood pressure monitor
(bosomedistars, Bosch + Sohn GmbH, Jungingen, Germany).
Tidal volume was measured using a metabolic cart (Oxycon Pro, Jaeger GmbH, Höchberg,
Germany). Data for tidal volume was recorded breath-by-breath during the HRV measure-
ment and averaged over the time period of each HRV segment in supine and sitting position.
Tidal volume was measured to monitor any possible influence of changing tidal volume on
HRV [28].
Blood sampling and analysis
Blood samples were taken subsequently after the HRV measurements from the antecubital
vein. Blood was drawn into 7 ml Lithium-Heparin tubes (S-Monovette, Sarestedt, Sevelen,
Switzerland) and centrifuged for 10 min at 4°C and 3000 rpmwithin a minute after bloodwith-
drawal. Centrifuged samples were pipetted into 1.5 ml aliquots and immediately frozen in liq-
uid nitrogen (Pangas, Dagmarsellen, Switzerland). They were stored at -80°C until analysis. All
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samples were sent deep frozen to an external laboratory (Institut für Klinische Chemie, Univer-
sitätsspital Zurich, Zurich, Switzerland) for analysis of caffeine concentration or to determine
epinephrine and norepinephrine concentrations (Division de pharmcologie clinique, Centre
Hospitalier Universitaire Vaudois, Lausanne, Switzerland). High performance liquid chroma-
tography (HPLC) was performed to determine these concentrations.
Caffeine and placebo administration
Randomization was applied using the data management software (SecuTrial, interActive Sys-
tems GmbH, Berlin, Germany) which randomized trials automatically. Randomization of
treatment sequence with a fixed block size of 5 and stratified by group was applied. Caffeine as
well as placebo were ingested in form of gelatin capsules either containing 50 or 100 mg. Pla-
cebo capsules were filledwith a sugar alcohol (mannitol), which was not expected to have any
further effects on performance. The caffeine capsules were filledwith pure caffeine powder.
Placebo and caffeine capsules were not distinguishable from each other due to equal color, size
and taste.
The dosage for each participant was calculated by multiplying bodymass with 6 which
equates a dosage of 6 mg caffeine per kg bodymass. As only 50 and 100 mg capsules were avail-
able, the dosages were then rounded up or down resulting in an actual dose varying from 5.8 to
6.2 mg/kg bodymass. The number of capsules was kept identical in the placebo trial. At the
end of each trial, participants were asked for their assumption concerning the type of capsules
swallowed. Additionally, gastrointestinal side effects were recorded.
Neither the head of study, nor participants and staff knew the assignment of interventions
during the study phase. The blinding process was done by the Clinical Trial Unit in our center
where the key for trial assignment was stored.
Statistics
A two-sided power analysis was performed. Applying a significance level of 0.05, a power of
0.8, a standard deviation of 5 Watt and an effect size of 1 resulted in an actual power of 0.84
and a total sample size of 9 participants per group. An additional over-recruitment by approxi-
mately 20% was anticipated in order to take possible drop-outs into account.
Data were tested for normal distribution using the Q-Q-plot, the Kolmogorov-Smirnov and
the Shapiro-Wilk test. Results are presented as median [minimum;maximum] as data was not
normally distributed. Statistical significance level was set at 0.05. To determine differences in
parameters between pre and post supplement ingestion or between placebo and caffeine trials
within the same group, theWilcoxon signed-rank test was applied. The Kruskal-Wallis test
was used to find any differences between the three groups whereas significant differences were
then located using the Mann-Whitney-U test as a post hoc analysis. Bonferroni corrections
were applied, where multiple testing with the Mann-Whitney-U test was done and the statisti-
cal significance level was then set to 0.0166. Spearman correlation was applied to find any rela-
tionship between habitual caffeine consumption and different parameter outcomes. Data are
presented as the p-value and the Spearman correlation coefficient.All calculations were per-
formed using the PSAW Statistics software (Version 18.0, SPSS Inc., Chicago, USA).
Results
In total 39 healthy non-smokingmen were recruited to participate in the study whereas 7 must
have been excluded due to not fulfilling inclusion criteria or due to participation declination.
Data was analyzed finally from 28 healthy, non-smokingmen (12 able-bodied, 9 paraplegic
and 7 tetraplegic participants) at the end of the study (Fig 1). Data from 4 participants were
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excluded for analysis due to incomplete HRV measurements (technical problems). Twelve able-
bodiedparticipants were selected to form a control group (median [minimum;maximum], age:
31 y [25; 52]; height: 182 cm [172; 190]; bodymass: 79 kg [67; 95]). Characteristics of paraplegic
and tetraplegic individuals are shown in Table 1. They were physically active during 7 h [3; 10]
(able-bodied), 8 h [3; 8] (paraplegic) and 2 h [2; 15] (tetraplegic) per week involving upper body
muscles. All participants were habitual caffeine consumers with a daily caffeine intake of 250 mg
[2; 600] for able-bodied, 250 mg [32; 440] for paraplegic and 200 mg [72; 420] for tetraplegic par-
ticipants. Data were collected between the July 2014 and January 2015.
Data for all HRV measurements pre and post ingestion of either caffeine or placebo are
shown for the supine and sitting position in Tables 2 and 3. Systolic and diastolic blood pres-
sure before and after the ingestion of any supplement are listed in Table 4. In able-bodied par-
ticipants, systolic and diastolic blood pressure increased by ~9 and ~8 mmHg respectively after
the ingestion of caffeine. Tetraplegic participants showed an increase of ~19 and ~27 mmHg in
systolic and diastolic blood pressure. In contrast, blood pressure did not increase significantly
in paraplegic participants nevertheless, the median systolic blood pressure was higher by 11
mmHg after the ingestion of caffeine.
Even thoughmetronomic breathing was applied, tidal volume increased significantly in
supine position after the ingestion of caffeine (Fig 2) compared to the measurement before the
ingestion in able-bodied and paraplegic participants. Comparing the change in tidal volume in
Fig 1. Participant recruitment flowchart.
doi:10.1371/journal.pone.0165034.g001
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supine position from pre to post ingestion in the placebo compared to the caffeine trial, only
able-bodiedparticipants showed a significant increase (Fig 3). Fig 4 shows the change in plasma
caffeine, epinephrine and norepinephrine concentrations from pre to post ingestion of either pla-
cebo or caffeine. Plasma epinephrine concentration increased significantly in able-bodied
(p = 0.002) and paraplegic (p = 0.032) but not in tetraplegic participants (p = 0.63) from pre to
post caffeine ingestion. Tidal volume and the difference of epinephrine concentration from pre to
post caffeine ingestion were significantly correlated only in able-bodiedparticipants (p = 0.038).
Change in HF from pre to post placebo ingestion was significantly correlated with total daily caf-
feine consumption in able-bodied (R = 0.61; p = 0.035) and in paraplegic (R = 0.70; p = 0.036)
but not in tetraplegic (R = 0.00; p = 1.00) participants. The same analysis in the caffeine trial did
not show a significant correlation in any group (able-bodied:R = 0.11; p = 0.74; paraplegic:
R = 0.13; p = 0.73; tetraplegic: R = 0.39; p = 0.38). The change of RMSSD in the placebo trial
showed a trend to correlate with total daily caffeine consumption in able-bodied (R = 0.52;
p = 0.081) and in paraplegic (R = 0.65; p = 0.058) but not in tetraplegic (p = 0.65) participants.
Change in LF/HF from pre to post caffeine ingestion was not significantly correlated to the
change in epinephrine concentration in the caffeine trial in any group of participants (able-bod-
ied: p = 0.39; paraplegic: p = 0.058; tetraplegic: p = 0.67). No gastrointestinal side effects occurred.
Discussion
Ingestion of 6 mg caffeine per kg bodymass leads to an increase in blood pressure and tidal vol-
ume in able-bodied, paraplegic and tetraplegic participants. It did not change most HRV indi-
ces significantly in these participants. Even though plasma caffeine concentration was
Table 1. Characteristics of spinal cord injured participants.
Lesion level AIS Age[years] Height [cm] Weight [kg] Time since injury [years] VO2peak [ml/min/kg]
Paraplegic participants
1 Th 10 A 32 183 73 16 38.4
2 Th 11 A 55 174 72 25 38.9
3 Th 11 A 59 178 80 41 19.5
4 Th 12 A 22 185 63 4 29.3
5 L 1 A 26 150 64 26 30.6
6 L 1 A 32 175 76 8 33.1
7 L 1 A 35 165 63 35 48.8
8 L 1 A 48 185 80 26 35.7
9 L 4 A 44 176 78 23 39.7
Median 43 [22; 59] 176 [150;185] 73 [63; 80] 25 [4; 41] 35.7 [19.5; 48.8]
Tetraplegic participants
1 C 5 A 23 188 85 5 13.4
2 C 5 A 43 176 80 3 11.5
3 C 5 A 65 190 75 37 16.3
4 C 6 A 31 180 60 12 13.6
5 C 6 A 56 170 74 45 8.6
6 C 7 A 31 190 80 14 14.8
7 C 7 A 40 168 60 7 15.3
Median 40 [24; 65] 180 [168; 190] 75 [60; 80] 12 [3; 45] 13.6 [8.6; 16.3]
Data presented as median [minimum; maximum]; AIS = American Spinal Injury Association Impairment Scale; SCI = spinal cord injury; VO2peak = peak
oxygen consumption, Th = thoracic; C = cervical; L = lumbar
doi:10.1371/journal.pone.0165034.t001
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significantly increased in all three groups of participants, plasma epinephrine increased only in
able-bodiedparticipants significantly.
Heart rate variability
To our knowledge, this study was the first one, assessing the influence of caffeine on HRV in
spinal cord injured compared to able-bodiedparticipants (Tables 2 and 3). HF significantly
Table 2. Heart rate variability (HF, LF, LF/HF and TP) pre and post ingestion of either placebo or caffeine supplementation in able-bodied, para-
plegic and tetraplegic participants in supine and sitting position.
Placebo Caffeine Δ p-value
Pre Post Pre Post
HF (supine) [ms2]
AB 723 [23; 3724] 1044 [25; 7154]* 689 [171; 5862] 1442 [168; 4517] 0.31
P 239 [20; 3376] 566 [60; 6092]* 487 [27; 1767] 659 [26; 2744] 0.07
T 757 [85; 6745] 784 [247; 4265] 848 [36; 2380] 666 [211; 3598] 0.87
HF (sitting) [ms2]
AB 1005 [19; 6088] 1341 [16; 5426] 415 [56; 7119] 1110 [136; 7039] 0.75
P 162 [23; 4670] 513 [29; 6971]* 373 [34; 1882] 465 [11; 2157] 0.038§
T 323 [17; 824] 477 [251; 2877] 275 [19; 2553] 508 [222; 2595] 0.61
LF (supine) [ms2]
AB 741 [124; 2477] 900 [99; 2581]* 375 [108; 3226] 789 [135; 3604]* 0.08
P 196 [53; 1865] 564 [42; 2803] 472 [69; 1272] 200 [40; 1612] 0.07
T 151 [14; 1180] 243 [87; 1549] 673 [10; 1018] 359 [126; 588] 0.13
LF (sitting) [ms2]
AB 1064 [88; 2325] 891 [147; 3063] 747 [107; 4384] 1037 [89; 4228] 0.48
P 357 [56; 3651] 1025 [77; 3136] 432 [95, 1730] 334 [35; 2622] 0.09
T 247 [2; 1089] 363 [42; 1126] 281 [16; 967] 313 [68; 648] 0.50
LF/HF (supine)
AB 1.08 [0.17; 5.31] 0.66 [0.18; 3.90] 0.72 [0.10; 1.01] 0.65 [0.15; 2.8] 0.31
P 0.90 [0.19; 13.10] 0.70 [0.29; 6.68] 0.70 [0.46; 9.65] 0.59 [0.24; 1.80] 0.95
T 0.25 [0.17; 0.87] 0.51 [0.18; 0.70] 0.80 [0.14; 2.75] 0.43 [0.10; 1.29] 0.31
LF/HF (sitting)
AB 1.57 [0.21; 4.55] 1.21 [0.36; 9.06] 1.27 [0.29, 7.18] 0.63 [0.25; 3.81] 0.39
P 1.56 [0.60; 7.83] 1.68 [0.45; 5.06] 0.98 [0.45; 12.68] 0.57 [0.19; 6.39]* 0.37
T 0.44 [0.10; 1.41] 0.76 [0.07; 1.73] 0.83 [0.38; 1.95] 0.56 [0.13; 1.09] 0.61
TP (supine) [ms2]
AB 1591 [180; 5938] 1901 [149; 9851]* 1159 [340; 8000] 3014 [401; 8265]* 0.53
P 437 [98; 5472] 1291 [106; 8391]* 1014 [189; 3120] 934 [78; 4566] 0.038§
T 951 [104; 7970] 1320 [442; 5894] 1346 [53; 3449] 942 [358; 4000] 0.87
TP (sitting) [ms2]
AB 2158 [111; 7538] 2172 [167; 8444] 1394 [186; 11733] 2589 [264; 11739] 0.75
P 634 [88; 9462] 1946 [189; 10507]* 1094 [264; 3743] 1159 [95; 4934] 0.015§
T 663 [30; 2024] 856 [341; 4180] 611 [36; 3582] 668 [473; 3221] 0.61
AB = able-bodied participants; P = paraplegic participants, T = tetraplegic participants; HF = high frequency power; LF = low frequency power; LF/HF = ratio
between LF and HF; TP = total power
* significant change from pre to post ingestion (p < 0.05)
§ significant difference between the changes in the placebo and the caffeine trial (p < 0.05)
Δ p-value = p-value comparing the difference between pre and post measurement of the placebo trial with the difference from the caffeine trials
doi:10.1371/journal.pone.0165034.t002
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increased in able-bodied as well as in paraplegic participants in the placebo trial but not in the
caffeine trial. LF did not change in any group at any trial. Furthermore, LF/HF ratio signifi-
cantly decreased in paraplegic participants following the ingestion of caffeine. In the other two
groups, a nonsignificant decrease in this ratio was found. TP increased significantly in able-
bodied and paraplegic participants in the placebo trial and only in able-bodied participants in
the caffeine trial. In addition, TP seemed to be lower from pre to post caffeine ingestion in
paraplegic and tetraplegic participants. A decrease of the heart rate during both trials seemed
to occur in all three groups, whereas it was not always a significant decrease. Overall, HRV
Table 3. MeanRR, SDNN, RMSSD and heart rate during rest in sitting and supine position.
Placebo Caffeine
Pre Post Pre Post Δ p-value
MeanRR (supine) [ms]
AB 1076 [823; 1273] 1240 [895; 1353]* 1108 [881; 1436] 1176 [1004; 1477] 0.53
P 922 [770; 1153] 1049 [910; 1262]* 974 [781; 1262] 1078 [857; 1449]* 0.77
T 1158 [908; 1326] 1247 [1036; 1415]* 1229 [829; 1355] 1347 [975; 1647]* 0.40
MeanRR (sitting) [ms]
AB 1088 [761; 1276] 1194 [786; 1377]* 991 [803; 1401] 1130 [892; 1358] 0.94
P 864 [707; 1111] 906 [756; 1180]* 946 [736; 1060] 995 [758; 1286]* 0.21
T 1130 [789; 1307] 1142 [900; 1223] 1139 [757; 1213] 1217 [867; 1633]* 0.50
SDNN (supine) [ms]
AB 44 [12; 82] 48 [11; 111] 34 [18; 94] 57 [18; 98]* 0.91
P 28 [10; 79] 36 [12; 107] 31 [13; 60] 39 [12; 69] 0.09
T 31 [11; 91] 38 [25; 87] 38 [8; 66] 42 [20; 65] 0.50
SDNN (sitting) [ms]
AB 49 [14; 89] 50 [17; 95] 39 [15; 99] 53 [19; 107] 0.75
P 29 [13; 95] 42 [14; 95]* 33 [17; 61] 33 [12; 74] 0.09
T 30 [6; 42] 35 [21; 66] 26 [7; 62] 33 [22; 66] 0.61
RMSSD (supine) [ms]
AB 50 [7; 126] 58 [9; 158]* 40 [21; 156] 71 [20; 130] 0.58
P 34 [7; 100] 43 [13; 136]* 35 [9; 70] 41 [9; 102] 0.11
T 41 [14; 130] 55 [33; 126] 52 [8; 99] 50 [27; 108] 0.74
RMSSD (sitting) [ms]
AB 53 [10; 138] 65 [10; 147] 30 [15; 161] 54 [21; 140]* 1.0
P 32 [9; 100] 38 [9; 107] 32 [11; 56] 35 [7; 70] 0.44
T 32 [7; 51] 40 [26; 84] 29 [7; 82] 43 [23; 103] 0.73
HR (supine) [1/min]
AB 56 [47; 73] 49 [45; 67]* 54 [42; 68] 52 [41; 61] 0.24
P 65 [52; 78] 57 [48; 66]* 62 [48; 77] 56 [41; 71]* 0.68
T 52 [45; 66] 48 [42; 58]* 49 [44; 72] 45 [36; 62]* 0.40
HR (sitting) [1/min]
AB 56 [47; 79] 51 [44; 76]* 60 [43; 75] 54 [45; 68] 0.94
P 70 [54; 85] 66 [51; 79]* 64 [57; 82] 61 [47; 79]* 0.52
T 53 [46; 76] 53 [49; 67] 53 [50; 79] 49 [37; 69] 0.74
AB = able-bodied participants; P = paraplegic participants, T = tetraplegic participants; MeanRR, = mean of the RR interval; SDNN = standard deviation of
all normal RR intervals; RMSSD = the squared root of the mean squared differences of successive RRI intervals; HR = heart rate
* significant change from pre to post ingestion (p < 0.05)
Δ p-value = p-value comparing the difference between pre and post measurement of the placebo trial with the difference from the caffeine trials
doi:10.1371/journal.pone.0165034.t003
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seemednot to be substantially changed following the ingestion of caffeine in paraplegic and tet-
raplegic participants even though significant differences in baseline LF values between the
Table 4. Blood pressure pre and post ingestion of either placebo or caffeine.
Placebo Caffeine
Pre Post Pre Post
Able-bodied
Systolic BP 110 [92; 125] 113 [96; 124] 107 [87; 137] 116 [106; 153]*
Diastolic BP 64 [51; 82] 67 [54; 83] 64 [51; 81] 72 [66; 102]*
Paraplegic
Systolic BP 108 [98; 128] 117 [98; 135]* 112 [100; 142] 123 [100; 153]
Diastolic BP 70 [53; 80] 75 [56; 83] 71 [58; 86] 73 [55; 92]
Tetraplegic
Systolic BP 100 [88; 122] 101 [90; 131] 100 [94; 110] 119 [95; 127]*
Diastolic BP 59 [48; 82] 58 [45; 88] 58 [54; 71] 85 [61; 105]*
Data presented as median [minimum; maximum]; BP = blood pressure
* = significant difference compared to pre ingestion (p < 0.05)
doi:10.1371/journal.pone.0165034.t004
Fig 2. Tidal volume in supine position pre and post ingestion of caffeine. * = outlier; § = significant difference
between pre and post (p < 0.05).
doi:10.1371/journal.pone.0165034.g002
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three groups were found. Tetraplegic participants showed the smallest values, which can be
explained by their impaired sympathetic function.
Fig 3. Differences in tidal volume (supine position) from pre to post ingestion between placebo and
caffeine trial. ˚ = outlier; * = extreme outlier; § = significant difference between the change from pre to post
caffeine compared to placebo ingestion (p < 0.05).
doi:10.1371/journal.pone.0165034.g003
Fig 4. Changes in plasma epinephrine (a), norepinephrine (b) and caffeine (c) concentrations from pre to post ingestion of the supplement
illustrated for all three groups. Dashed line represents placebo trail, bold line represents caffeine trial; ●,  = able-bodied, ■, □ = paraplegic and ▲, Δ =
tetraplegic group.
doi:10.1371/journal.pone.0165034.g004
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Hibino, Moritani [33] showed a significant increase in HF and TP in normal healthy popu-
lation after consummation of 240 mg caffeine. In addition, they observed a great variability in
LF/HF, whereas results couldn`t be presented. They suggested, that coffee intake induced calm-
ness and that only the relaxing effect of caffeine was seen in the HRV. Additionally, they sup-
pose, that an increasing tidal volume might increase HF. Therefore, it is possible, that our HF
parameters in the caffeine trial were overrated due to the increase in tidal volume. No studies
were found showing the impact of altered tidal volume on HRV. Monda, Viggiano [34] found
an increase in HF after the ingestion of 75 mg caffeine in form of espresso but no change in LF.
Similar results were found by Notarius and Floras [35] in healthy participants, whereas the
ingestion of 4 mg caffeine per kg bodymass increased LF, HF and TP with a decrease in LF/HF
ratio. In contrast, they found no change in HRV in patients with a chronic heart failure where
caffeine infusion did not alter any HRV parameter. In comparison, our results showed a trend
toward a reduction of LF/HF ratio as well, even if this reductionwas only significant in paraple-
gic participants. In contrast, LF and HF were not altered following caffeine ingestion. Two
other studies [36, 37] have shown a decrease in LF/HF ratio following caffeine ingestion. Rich-
ardson, Rozkovec [36] investigated the ingestion of two times 250 mg caffeine in patients suf-
fering from diabetes compared to a control. They showed a reduction in sympathetic and an
increase in parasympathetic activity. LF/HF ratio was significantly reduced in diabetes patients
following caffeine ingestion. Rauh, Burkert [37] showed a decreased LF/HF ratio following the
ingestion of 200 mg caffeine. In addition, a lower heart rate was shown in all trials (even pla-
cebo), but it was not significant. These results are very similar to ours, as we have found signifi-
cant reductions of heart rate in both trials in all participants. This reductionmight be
explained by the increase of cardiac parasympathetic activity. The increase in HF in the placebo
trial in paraplegic and able-bodied participants seems to positively correlate with daily caffeine
consumption. One can hypothesize, that in these trials, missing caffeine consumption did acti-
vate parasympathetic nerve activity to a greater extent than in the caffeine trial. Since Ditor,
Kamath [12] showed, that HF is not reliable in spinal cord injured individuals, it is difficult to
draw final conclusions concerning the effects of caffeine.
Comparing LF pre ingestion of the supplement, we detect a significant difference between
our three groups. The lowest LF was found for tetraplegic participants whereas able-bodied
showed the highest LF. Even for paraplegic participants, LF was significantly reduced, com-
pared to able-bodied participants. These findings are in line with the results from Inoue, Ogata
[22] where they showed only HF and no LF in 9 of 15 tetraplegic participants. The other 6 par-
ticipants showed a significantly lower LF compared to 10 able-bodied controls. In paraplegic
participants, both LF and HF were represented, but they were reduced compared to able-bod-
ied controls. Furthermore, they concluded, that LF implies other physiological mechanisms
than in able-bodied controls. Two other studies [13, 19] investigated HRV in spinal cord
injured participants. Both studies found a lower in LF in paraplegic participants compared to
able-bodied.HF seemed to be similar in all different groups of participants. Conclusively, LF
seems to be present in highly lesioned tetraplegic participants showing a motor and sensory
completely lesion but it seems to be significantly reduced compared to paraplegic and able-
bodied participants. Thus, these results might support the theory that LF implies 25% parasym-
pathetic and 50% sympathetic nerve activity [8].
Blood pressure and tidal volume
Systolic and diastolic blood pressure increased in all three groups, whereas the increase was
only significant in the able-bodied and tetraplegic participants (Table 4). The increase of blood
pressure was the highest in tetraplegic participants with an increase of 19 mmHg in systolic
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and with 27 mmHg in diastolic blood pressure. Such an increase of blood pressure following
the ingestion of caffeine was found in several different able-bodied studies and was reviewed by
Nurminen, Niittynen [38]. Even in tetraplegic participants a significant increase in systolic and
diastolic blood pressure was found 60 min and 75 min after the ingestion of caffeine [23].
Another study showed a significant increase in mean arterial pressure (MAP) in tetraplegic
participants after the ingestion of 4 mg caffeine per kg bodymass [39]. A case report showed
that the ingestion of caffeine leads to increased blood pressure in a paraplegic participant with
a lesion sub Th3 [40]. To summarize, blood pressure might be increased either due to an
increase in epinephrine concentration activating the sympathetic nervous system by increasing
blood pressure as well. Otherwise, caffeinemight directly act on adenosine and ryanodine
receptors on heart muscle tissue increasing contractility of the heart leading to an increase in
stroke volume. The physiological consequence of an increased stroke volume is an increase in
systolic blood pressure. From a clinical point of view, a higher blood pressure can be of interest
for individuals with a spinal cord injury in two ways. First, many persons with a spinal cord
injury suffer from orthostatic hypotension, which affects quality of daily living. The ingestion
of caffeine might help to alleviate symptoms such as dizziness. Second, for wheelchair athletes,
an increase in systolic blood pressure induces a higher cardiac output leading to a better exer-
cise performance. thus, caffeinemight be of interest as an ergogenic aid in athletes with a spinal
cord injury. In fact, some studies [30, 41] were showing potential benefits of caffeine supple-
mentation. However, further studies are needed to elucidate this issue in more detail.
Similar to our blood pressure results, tidal volume increased significantly after the ingestion
of caffeine in able-bodied as well as in paraplegic participants (Figs 2 and 3). We did not find
any significant increase in tidal volume in our tetraplegic participants even though it tended to
be higher. Similar results were shown, when 5 mg caffeine per kg bodymass was administrated
[42]. A significant increase in tidal volume was shown and authors concluded, caffeine might
be a respiratory stimulant. Similar findings were shown by Kraaijenga, Hutten [43], whereas
intravenous caffeine administration increased tidal volume significantly in preterm infants due
to increased diaphragmatic contractility. On the other hand, caffeine did not change respira-
tory rate. They suggested, that contractility might be increased due to augmented release of cal-
cium in the sarcoplasmic reticulum [44]. Another possibility to increase contractility might
involve the adrenal release of epinephrine concentration, which was not present in our partici-
pants. Therefore, we speculate, that if tidal volume was increased due to increased diaphrag-
matic contractility, the major mechanism would probably involve calcium release in the
sarcoplasmic reticulum in our spinal cord injured participants. This suggestion is supported by
our results, showing a significant correlation of epinephrine increase with tidal volume increase
in able-bodied participants. Thus, the release of epinephrine would only play a minor role in
increasing tidal volume.
Blood parameters
Plasma epinephrine concentrations significantly increased following caffeine ingestion in able-
bodied, as well as in paraplegic but not in tetraplegic participants (Fig 4). Plasma norepineph-
rine concentration on the other hand, did not increase due to caffeine in all three groups. Simi-
lar results were found by Mohr, Van Soeren [45] whereas one paraplegic individual was able to
increase plasma epinephrine and norepinephrine concentration following the ingestion of 6
mg caffeine per kg bodymass. The other six tetraplegic individuals did not show any increase
in epinephrine and norepinephrine concentration. Another study [23] conducted with tetra-
plegic participants did not show a significant increase in plasma epinephrine and norepineph-
rine concentration following the ingestion of caffeine. Nevertheless, Van Soeren,Mohr [23]
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were able to detect a significant increase in plasma caffeine concentration with a peak concen-
tration after 40 min. These results are in line with our own findings where we have found a sig-
nificant increase in plasma caffeine concentration in tetraplegic participants but no increase in
epinephrine and norepinephrine. It seems evident, that the ability to increase epinephrine and
norepinephrine concentration depends on the level of lesion which influences sympathetic ner-
vous system activity. Steinberg, Lauro [46] showed a significant increase in epinephrine and
norepinephrine concentration from pre to post exercise performance in low lesioned paraple-
gic participants whereas high lesioned paraplegic participants showed only an increase in nor-
epinephrine concentration. Schmid, Huonker [47] examined the same parameters in
tetraplegic participants (even higher lesioned than high lesioned paraplegic participants). They
found lower epinephrine and norepinephrine concentrations at rest in tetraplegic compared to
able-bodiedparticipants. In addition, they did not find any significant increase in epinephrine
and norepinephrine concentrations from rest to maximal exercise performance in tetraplegic
participants. These studies showed a diminished function of the sympathetic nervous system
dependent of the lesion level in case of a spinal cord injury. This is very important when it
comes to caffeine supplementation in order to increase sympathetic nervous system activity.
This hypothesis is supported by findings of Flueck, Lienert [30] whereas the ingestion of caf-
feine in a group of tetraplegic individuals showed no ergogenic effect. In summary, it is very
important to know, whether these participants are able to increase sympathetic modulation
through caffeine consumption and to what extent.
Limitations
Respiration seemed to influenceHRV [48], which could confound our study results. We stan-
dardized breathing throughmetronomic breathing strategy but we did not standardize tidal vol-
ume. Through the ingestion of caffeine, tidal volume was increased, which would influenceHRV.
Nevertheless, HRV was shown to be reproducible in spinal cord injured participants [12], there-
fore, we assume our measures to be reliable. However, HF seemed to be influencedby a change
in tidal volume [33, 48] and maybe that’s the reason why this parameter was not reliable in spinal
cord injured participants [12]. In addition, all our participants were regular caffeine users who
were limited in caffeine consume 12 hours before the trials.Maybe, we should have restricted caf-
feine consume the last week before the trials or should have chosen caffeine nonusers, which
would have been a challenge in this specific group of participants. Thus, there would be no need
to discuss the reason for an increase in HF in the placebo trial compared to the caffeine trial.
Conclusion
To conclude, LF/HF seemed to be decreased after caffeine ingestion in all of our participants
with a significant decrease in the paraplegic group. Systolic and diastolic blood pressure, as well
as tidal volume increased following the ingestion of caffeine with a significant decrease in heart
rate in both, placebo and caffeine, trials. Able-bodied and paraplegic participants were able to
increase epinephrine concentrations even though all of our participants showed an increase in
plasma caffeine concentrations. The influence of caffeine on the autonomic nervous system
seems to depend on the level of lesion and the extent of the impairment. Therefore, tetraplegic
participants may be less influenced by caffeine and they would probably benefit less in terms of
activating the sympathetic nervous system.
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